Meridian Bioscience Inc. Aktie
Finanztrends
Deine Einschätzung
Meridian Bioscience Inc. Aktie
Für die Meridian Bioscience Inc. Aktie identifiziert die Community ausschließlich positive Aspekte, insbesondere wird das Thema Lohnenswerte Investition für die nächsten Jahre gelobt.
Was spricht für und gegen Meridian Bioscience Inc. in den nächsten Jahren?
Pro
?
M****
?
L*********** I********** f** d** n******* J****
?
A****************
Kontra
?
U****************
?
W******* i* V********
?
M************
Sag auch du uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Meridian Bioscience Inc. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Meridian Bioscience Inc. | - | - | - | - | - | - | - |
| SI-BONE Inc | 0,89 % | 0,00 % | -17,91 % | -16,67 % | -34,91 % | - | - |
| Lantheus Holdings Inc | -0,55 % | -0,36 % | 1,13 % | -26,48 % | 15,42 % | -13,70 % | - |
| Orasure Tech | 1,53 % | 1,53 % | 6,40 % | -13,07 % | 29,13 % | -49,81 % | -73,01 % |
Kommentare
News
Atlas Energy Stock Jumps 39% YTD, but One Fund Cut Exposure by $15 Million Last Quarter
On February 17, 2026, Meridian Wealth Advisors disclosed a reduction in its Atlas Energy Solutions (NYSE:AESI) position, selling 1,458,193 shares for an estimated $14.74 million based on average
This REIT Is Down 60% Since 2006, but a $9.2 Million Bet Says There’s Still Value
New York City-based DSC Meridian Capital initiated a new position in Elme Communities (NYSE:ELME), acquiring 543,081 shares valued at approximately $9.2 million, according to a November 14 SEC
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
New York City-based DSC Meridian Capital fully exited its position in Bausch + Lomb during the third quarter, reducing its holdings by 510,090 shares, a move totaling approximately $6.6 million.